A detailed history of Monaco Asset Management Sam transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 203,426 shares of VNDA stock, worth $978,479. This represents 0.14% of its overall portfolio holdings.

Number of Shares
203,426
Previous 192,926 5.44%
Holding current value
$978,479
Previous $1.09 Million 12.48%
% of portfolio
0.14%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.61 - $6.34 $48,405 - $66,570
10,500 Added 5.44%
203,426 $954,000
Q2 2024

Aug 07, 2024

BUY
$3.91 - $6.5 $754,340 - $1.25 Million
192,926 New
192,926 $1.09 Million
Q4 2023

Feb 07, 2024

SELL
$3.38 - $4.58 $169,000 - $229,000
-50,000 Reduced 37.04%
85,000 $358,000
Q3 2023

Nov 07, 2023

BUY
$4.28 - $6.57 $577,800 - $886,950
135,000 New
135,000 $583,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $272M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.